Point of Care (POC) Diagnostics Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

Point of Care (POC) Diagnostics Market – Report Overview

Pacific Business Consulting’s “Point of Care (POC) Diagnostics Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Point of Care (POC) Diagnostics market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

In 2022, the Point of Care (POC) Diagnostics market surpassed a valuation of US$ 41.0 Billion and is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) exceeding 8.0% from 2023 to 2030. The market is anticipated to potentially surpass US$ 65.0 Billion by 2030.

The growth of the analyzed market is driven by several factors, including the increasing prevalence of chronic and infectious diseases, a rise in regulatory approvals for innovative immunoassay techniques and technological advancements, and the growing use of home-based point-of-care (POC) devices.

The global increase in chronic and infectious diseases, such as diabetes, rheumatism, and malaria, is fueling the demand for POC diagnostics. For example, the World Health Organization (WHO) reported in December 2022 that malaria cases reached an estimated 247 million worldwide in 2021. Similarly, a study by NCBI in May 2021 revealed a global prevalence of 460 cases of rheumatoid arthritis (RA) per 100,000 population during 2020-2021. The escalating number of these diseases globally is boosting the need for rapid diagnostics, consequently driving the demand for POC diagnostics and the overall market growth.

The COVID-19 pandemic significantly influenced the POC diagnostics market, with the emergence of rapid COVID-19 testing becoming essential for containment and mitigation. However, in the current scenario, the convenience, affordability, reduced complications, and faster turnaround times of POC diagnostics are expected to drive substantial growth over the forecast period.

Furthermore, the market is expected to benefit from the increasing number of regulatory approvals for novel immunoassay techniques, technological advancements, and the rising use of home-based POC devices. For instance, in July 2022, BioGX launched a CE-marked, three-gene multiplex POC COVID-19 test, contributing to market growth through regulatory approvals for innovative products.

An article by Mylab Discovery Solutions in March 2022 highlighted the significance of POC diagnostics, particularly in low and middle-income countries, where uneven healthcare distribution makes POC tests a crucial tool for increasing diagnostic coverage. The demand for POC is constantly rising, contributing to the growth of the studied market.

Despite these positive trends, factors such as product recalls by major market players, stringent regulatory policies, and reimbursement issues may impede market growth during the forecast period.

The COVID-19 pandemic disrupted the supply chain and hindered manufacturers from receiving substantial raw materials from across borders. Increased funding from sources like the U.S. Department of Defense, the NIH, and private foundations, including the Bill & Melinda Gates Foundation, is expected to drive the point-of-care testing (POCT) market. Initiatives such as the joint effort by Grand Challenges Canada and the Bill & Melinda Gates Foundation focus on developing interoperable POC platforms with a “plug-and-play” characteristic feature, accommodating diverse tests from various developers.

The integration of digital technologies is anticipated to have a significant impact on expanding POC solutions in limited resource settings. The rise in telehealth adoption, with approximately 95% of U.S. health centers offering telehealth services during the pandemic, is considered a critical go-to-market strategy for POCT players. Remote patient monitoring systems, such as PixCell Medical for CBC tests, are expected to positively impact market growth.

The increasing importance of POC diagnostics in environmental monitoring and public health necessitates the integration of technologies that facilitate easy networking, making it convenient for healthcare professionals to interpret test results accurately. Companies are developing affordable POC with high specificity and sensitivity, such as Everything Genetic’s approval for selling COVID-19 Antigen Tests in the U.K. market, which is expected to boost market growth, especially in developing economies.

Key players in the Point of Care (POC) Diagnostics segment, including Johnson and Johnson Inc., Nova Biomedical Corporation, Qiagen Inc., F. Hoffmann-La Roche Ltd., and Biomeriux SA, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation (Beckman Coulter Inc.), Becton, Dickinson and Company, Instrumentation Laboratory, are expected to play a crucial role in shaping the future landscape of Point of Care (POC) Diagnostics technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Point of Care (POC) Diagnostics market. It also delves into the analysis of present and prospective market competition within the global Point of Care (POC) Diagnostics market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Point of Care (POC) Diagnostics market across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Point of Care (POC) Diagnostics market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

1. Executive Summary: Point of Care (POC) Diagnostics
   • Global Market Outlook: Point of Care (POC) Diagnostics
2. Competitive Intelligence Analysis: Point of Care (POC) Diagnostics
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Point of Care (POC) Diagnostics
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: Point of Care (POC) Diagnostics
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. Point of Care (POC) Diagnostics: Ten Major Market (10MM) – Market Analysis, By Product Type
   • Glucose Testing
   • Cardiometabolic Monitoring
   • Coagulation Testing
   • Fertility/Pregnancy
   • Infectious Disease
   • Cardiac Markers
   • Cancer Marker
   • Blood Gas/Electrolytes
   • Decentralized Clinical Chemistry
   • Lipid Testing
   • Ambulatory Chemistry
   • Drug of Abuse (DOA) Testing
   • Urinalysis/Nephrology
   • Thyroid Stimulating Hormone
   • Others
9. Point of Care (POC) Diagnostics: Ten Major Market (10MM) – Market Analysis, By Platform
   • Dipsticks
   • Lateral Flow Assays
   • Molecular Diagnostics
   • Immunoassays
   • Microfluidics
10. Point of Care (POC) Diagnostics: Ten Major Market (10MM) – Market Analysis, By End User
    • Hospitals & Clinics
    • Home Care & Self Testing
    • Pharmacies & Drug Stores
    • E-commerce Platforms
    • Ambulatory Surgical Centers
    • Others
11. Point of Care (POC) Diagnostics: Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By End User
      • By Platform
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By End User
      • By Platform

12. S. Point of Care (POC) Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By End User
      • By Platform
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By End User
      • By Platform

13. K. Point of Care (POC) Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By End User
      • By Platform
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By End User
      • By Platform

14. Germany Point of Care (POC) Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By End User
      • By Platform
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By End User
      • By Platform

15. France Point of Care (POC) Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By End User
      • By Platform
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By End User
      • By Platform

16. Italy Point of Care (POC) Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By End User
      • By Platform
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By End User
      • By Platform

17. Spain Point of Care (POC) Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By End User
      • By Platform
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By End User
      • By Platform

18. Japan Point of Care (POC) Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By End User
      • By Platform
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By End User
      • By Platform

19. China Point of Care (POC) Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By End User
      • By Platform
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By End User
      • By Platform

20. Australia Point of Care (POC) Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By End User
      • By Platform
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By End User
      • By Platform

21. India Point of Care (POC) Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By End User
      • By Platform
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By End User
      • By Platform

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer